prof. MUDr. Jindřich Špinar, CSc.
Professor, First Department of Internal Medicine - Cardioangiology
Correspondence Address:
Pekařská 664/53, 602 00 Brno
Phone: | +420 532 23 2601 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1170
2019
-
Position statement ESC k perorálním antidiabetikům a srdečnímu selhání.
Acta Medicinae, year: 2019, volume: 15, edition: 2
-
Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry
Plos one, year: 2019, volume: 14, edition: 3, DOI
-
Studie DECLARE potvrdila příznivý efekt dapagliflozinu.
Kardiologická revue, year: 2019, volume: 21, edition: 1
-
Studie DECLARE přepisuje guidelines.
Výhledy a výzvy diabeteologie, year: 2019, volume: 20, edition: 1
-
Studie MARINER
Remedia, year: 2019, volume: 29, edition: 2
-
Těhotenství u pacientky s funkčně jedinou komorou (fontanovská cirkulace)
Cor et Vasa Case Reports, year: 2019, volume: 2019, edition: 1
2018
-
Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality
European Journal of heart Failure, year: 2018, volume: 20, edition: 3, DOI
-
Altered mental status predicts mortality in cardiogenic shock - results from the CardShock study
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, year: 2018, volume: 7, edition: 1, DOI
-
Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications
Clinical Research in Cardiology, year: 2018, volume: 107, edition: 3, DOI
-
Dapagliflozin a studie DECLARE – vstupní charakteristika
Kardiologická revue - Interní medicína, year: 2018, volume: 20, edition: 1